TransMedics Group Inc
NASDAQ: TMDX · HEALTHCARE · MEDICAL DEVICES
Updated 2026-06-05
TransMedics Group Inc (TMDX) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-17.55M | — | — | — |
| 2016 | $6.21M | $-24.07M | 12.34% | -370.20% | -387.58% |
| 2017 | $7.68M | $-20.82M | 27.81% | -265.79% | -270.96% |
| 2018 | $13.02M | $-23.76M | 44.05% | -155.47% | -182.50% |
| 2019 | $23.60M | $-33.55M | 58.73% | -125.42% | -142.12% |
| 2020 | $25.64M | $-28.75M | 64.88% | -102.91% | -112.13% |
| 2021 | $30.26M | $-44.22M | 69.92% | -130.29% | -146.11% |
| 2022 | $93.46M | $-36.23M | 69.84% | -33.64% | -38.77% |
| 2023 | $241.62M | $-25.03M | 63.77% | -11.89% | -10.36% |
| 2024 | $441.54M | $35.46M | 59.36% | 8.49% | 8.03% |
| 2025 | $605.49M | $190.29M | 59.92% | 17.93% | 31.43% |
Frequently asked questions
What is TransMedics Group Inc's revenue?
TransMedics Group Inc's trailing twelve-month revenue is $635.89M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is TMDX?
In its most recent fiscal year, TMDX ran a gross margin of 59.92%, an operating margin of 17.93%, and a net margin of 31.43%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does TMDX generate?
TMDX produced $133.59M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is TMDX's balance sheet healthy?
TMDX holds $488.37M in cash and equivalents against $502.39M in long-term debt, on $473.10M of shareholder equity. That debt is best read against the cash flow the business throws off each year.